Additional file 4: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
Geraldine Vijay
Na Zhao
Petra Hollander
Mike Toneff
Robiya Joseph
Mika Pietila
Joseph Taube
Tapasree Sarkar
Esmeralda Ramirez-Pena
Steven Werden
Maryam Shariati
Ruli Gao
Mary Sobieski
Clifford Stephan
Nathalie Sphyris
Noayuki Miura
Peter Davies
Jeffrey Chang
Rama Soundararajan
Jeffrey Rosen
Sendurai Mani
10.6084/m9.figshare.7818722.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_4_of_GSK3_regulates_epithelial-mesenchymal_transition_and_cancer_stem_cell_properties_in_triple-negative_breast_cancer/7818722
Figure S2. The drugs that were selected from the screen were validated using FACS. The MDA MB 231 reporter cells were treated with all the 11 drugs selected from the screen. Following treatment, the percentage of cells fluorescing red and green were assessed using flow cytometry and plotted for each of the three concentrations to generate the graphs. (PDF 160âkb)
2019-03-07 05:00:00
Triple-negative breast cancer (TNBC)
Epithelial-mesenchymal transition (EMT)
Cancer stem cells (CSCs)
Glycogen synthase kinase β (GSK3β)
Wnt signaling